Login / Signup

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

Ryusuke YamamotoNobuhiro HiramotoAyumi FujimotoHirohito YamazakiTakehiko MoriNaoyuki UchidaKazuteru OhashiJun KatoMasashi NishikuboShinichi KakoTetsuya NishidaShuichi OtaMakoto OnizukaTetsuya EtoKoichi OnoderaKazuhiro IkegameKen-Ichi MatsuokaYoshinobu KandaTakahiro FukudaYoshiko AtsutaYasushi Onishi
Published in: Bone marrow transplantation (2024)
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • ejection fraction
  • stem cell transplantation
  • prognostic factors
  • bone marrow
  • patient reported outcomes
  • hematopoietic stem cell